Loading...
Stryker Corporation
SYK•NYSE
HealthcareMedical - Devices
$384.07
$0.97(0.25%)
Stryker Corporation (SYK) Financial Performance & Statements
Review Stryker Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
10.23%
↑ 10.23%
Operating Income Growth
-5.12%
↓ 5.12%
Net Income Growth
-5.43%
↓ 5.43%
Operating Cash Flow Growth
14.31%
↑ 14.31%
Operating Margin
15.77%
↑ 15.77%
Gross Margin
63.57%
↑ 63.57%
Net Profit Margin
12.31%
↑ 12.31%
ROE
10.73%
↑ 10.73%
ROIC
9.61%
↑ 9.61%
Stryker Corporation (SYK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Stryker Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.44B | $5.49B | $5.42B | $5.24B |
| Cost of Revenue | $2.26B | $1.98B | $2.10B | $2.06B |
| Gross Profit | $4.17B | $3.52B | $3.32B | $3.18B |
| Gross Profit Ratio | $0.65 | $0.64 | $0.61 | $0.61 |
| R&D Expenses | $369.00M | $377.00M | $352.00M | $368.00M |
| SG&A Expenses | $2.13B | $1.90B | $1.81B | $1.84B |
| Operating Expenses | $3.59B | $2.43B | $2.17B | $2.21B |
| Total Costs & Expenses | $5.86B | $4.41B | $4.26B | $4.27B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $264.00M | $268.00M | $258.00M | $260.00M |
| EBITDA | $1.82B | $1.35B | $1.31B | $1.23B |
| EBITDA Ratio | $0.28 | $0.25 | $0.24 | $0.23 |
| Operating Income | $581.00M | $1.08B | $1.16B | $976.00M |
| Operating Income Ratio | $0.09 | $0.20 | $0.21 | $0.19 |
| Other Income/Expenses (Net) | -$53.00M | -$42.00M | -$53.00M | -$49.00M |
| Income Before Tax | $528.00M | $1.04B | $998.00M | $923.00M |
| Income Before Tax Ratio | $0.08 | $0.19 | $0.18 | $0.18 |
| Income Tax Expense | -$18.00M | $209.00M | $173.00M | $135.00M |
| Net Income | $546.00M | $834.00M | $825.00M | $788.00M |
| Net Income Ratio | $0.08 | $0.15 | $0.15 | $0.15 |
| EPS | $1.43 | $2.19 | $2.17 | $2.07 |
| Diluted EPS | $1.42 | $2.16 | $2.14 | $2.05 |
| Weighted Avg Shares Outstanding | $381.00M | $381.10M | $381.00M | $380.40M |
| Weighted Avg Shares Outstanding (Diluted) | $386.10M | $385.60M | $385.40M | $385.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan